News & Updates

Rhythm control therapy beneficial in AF with heart failure when initiated early

06 Aug 2021 by

Starting rhythm control therapy with antiarrhythmic drugs or ablation within a year following diagnosis of atrial fibrillation (AF) in patients with heart failure helps improve cardiovascular outcomes, and this clinical benefit is seen across ejection fraction ranges, according to subgroup analysis of the EAST-AFNET4 trial.

Rhythm control therapy beneficial in AF with heart failure when initiated early

06 Aug 2021

Alteplase can stave off death in stroke patients with AF not undergoing thrombectomy

04 Aug 2021 by

The thrombolytic drug alteplase appears to confer survival gains in acute ischaemic stroke patients with atrial fibrillation (AF), especially those who are not undergoing mechanical thrombectomy (MT), as shown in the IAC (Initiation of Anticoagulation After Cardioembolic Stroke) study.

Alteplase can stave off death in stroke patients with AF not undergoing thrombectomy

04 Aug 2021

Childhood primary snoring may induce poor endothelial function, high ambulatory BP

04 Aug 2021

Primary snoring (PS) during childhood leads to poorer endothelial function, greater carotid intima-media thickness (cIMT), and higher ambulatory blood pressure (ABP) at 5-year follow-up regardless of change in obstructive sleep apnoea severity, a study has found.

Childhood primary snoring may induce poor endothelial function, high ambulatory BP

04 Aug 2021

mRNA COVID-19 vaccines: Benefits far outweigh the risk

04 Aug 2021 by

The benefits of mRNA* COVID-19 vaccines far outweigh the very small risk of vaccine-related myocarditis, says the US Centers for Disease Control and Prevention (CDC).

mRNA COVID-19 vaccines: Benefits far outweigh the risk

04 Aug 2021

Endovascular therapy improves stroke outcomes in patients with prestroke disability

03 Aug 2021

In patients with prestroke disability, endovascular therapy (EVT) has a more favourable effect on stroke outcomes compared with medical management, according to a study.

Endovascular therapy improves stroke outcomes in patients with prestroke disability

03 Aug 2021

Breastfeeding boosts heart health in children

02 Aug 2021 by

Breastfeeding appears to confer antihypertensive benefit in children, such that those who have ever breastfed have lower blood pressure (BP) at 3 years of age, even if they only received breast milk in the first few days of life, according to data from the CHILD* Cohort Study.

Breastfeeding boosts heart health in children

02 Aug 2021

Apixaban bests other DOACs in reducing adverse events among frail AF patients

02 Aug 2021

Treatment with apixaban leads to reduced rates of adverse events across all frailty levels among older adults with atrial fibrillation (AF), reports a study. In contrast, dabigatran and rivaroxaban help lower event rates only among nonfrail patients.

Apixaban bests other DOACs in reducing adverse events among frail AF patients

02 Aug 2021

RBCs from pre-eclamptic women induce endothelial dysfunction

01 Aug 2021

Red blood cells (RBCs) play a key role in facilitating the association between endothelial dysfunction and pre-eclampsia through arginase-dependent and oxidative stress-dependent mechanisms, according to a recent study. Thus, targeting of RBC arginase may provide a novel treatment modality of pre-eclampsia.

RBCs from pre-eclamptic women induce endothelial dysfunction

01 Aug 2021

MI, stroke history heighten risk of same CV events

01 Aug 2021

Previous myocardial infarction (MI) and stroke appear to increase the risk for the same events in the future regardless of achieved systolic blood pressure (SBP), reports a study.

MI, stroke history heighten risk of same CV events

01 Aug 2021

Empagliflozin exerts null effect on myocardial reserve flow in T2DM

31 Jul 2021

Empagliflozin falls short of improving myocardial reserve flow in type 2 diabetes mellitus (T2DM) patients at high risk of cardiovascular disease, according to data from the SIMPLE trial*.

Empagliflozin exerts null effect on myocardial reserve flow in T2DM

31 Jul 2021

News & Updates

Filter by Specialty:

Specialty:

Rhythm control therapy beneficial in AF with heart failure when initiated early

Rhythm control therapy beneficial in AF with heart failure when initiated early

Alteplase can stave off death in stroke patients with AF not undergoing thrombectomy

Alteplase can stave off death in stroke patients with AF not undergoing thrombectomy

Childhood primary snoring may induce poor endothelial function, high ambulatory BP

Childhood primary snoring may induce poor endothelial function, high ambulatory BP

mRNA COVID-19 vaccines: Benefits far outweigh the risk

mRNA COVID-19 vaccines: Benefits far outweigh the risk

Endovascular therapy improves stroke outcomes in patients with prestroke disability

Endovascular therapy improves stroke outcomes in patients with prestroke disability

Breastfeeding boosts heart health in children

Breastfeeding boosts heart health in children

Apixaban bests other DOACs in reducing adverse events among frail AF patients

Apixaban bests other DOACs in reducing adverse events among frail AF patients

RBCs from pre-eclamptic women induce endothelial dysfunction

RBCs from pre-eclamptic women induce endothelial dysfunction

MI, stroke history heighten risk of same CV events

MI, stroke history heighten risk of same CV events

Empagliflozin exerts null effect on myocardial reserve flow in T2DM

Empagliflozin exerts null effect on myocardial reserve flow in T2DM